Retour sur lavenir.net
   LOTUS BAKERIES 9 940.000 € (+0,40 %)     VASTNED 29.700 € (+0,34 %)     INCLUSIO SA/NV 17.600 € (+0,28 %)     TUBIZE-FIN 219.500 € (+0,69 %)     UCB 264.500 € (-1,23 %)     ARGENX SE 647.200 € (+0,22 %)     RETAIL ESTATES 68.300 € (+1,79 %)     WDP 23.480 € (+0,77 %)     SOLVAY 26.700 € (-0,15 %)     ASCENCIO 49.800 € (+2,26 %)     VGP 86.900 € (0,00 %)     EXMAR 10.140 € (+1,00 %)     UMICORE 16.350 € (-1,39 %)     NYXOAH 3.040 € (+13,64 %)     EKOPAK 4.600 € (-5,93 %)     QUESTFOR GR-PRICAF 2.810 € (-1,40 %)     WERELDHAVE BELGIUM 55.000 € (+0,73 %)     JENSEN-GROUP 66.200 € (-1,19 %)     SIPEF 97.800 € (+0,41 %)     SOFINA 214.200 € (-0,28 %)     WHAT''S COOKING GP 142.000 € (+0,71 %)     ONWARD MEDICAL 3.235 € (-5,27 %)     D'IETEREN GROUP 161.700 € (-1,76 %)     CAMPINE 198.000 € (+1,54 %)     TINC 11.720 € (+0,69 %)     KBC 108.700 € (-1,05 %)     DEME GROUP 190.000 € (-0,52 %)     AB INBEV 61.500 € (+1,25 %)     MELEXIS 54.050 € (-1,46 %)     DECEUNINCK 2.045 € (-0,97 %)     FAGRON 22.100 € (+1,38 %)     RECTICEL 9.620 € (-2,04 %)     CENERGY 19.240 € (-1,33 %)     AZELIS GROUP 8.935 € (+2,00 %)     COFINIMMO 83.900 € (+0,66 %)     SYENSQO 47.540 € (-3,59 %)     KBC ANCORA 72.500 € (-0,68 %)     EVS BROADC.EQUIPM. 33.750 € (-1,46 %)     GIMV 46.200 € (+1,09 %)     FLUXYS BELGIUM D 20.900 € (-2,79 %)     PROXIMUS 6.985 € (-1,48 %)     KINEPOLIS GROUP 26.600 € (+0,38 %)     ACKERMANS V.HAAREN 272.200 € (+0,37 %)     MONTEA 67.400 € (+0,30 %)     ELIA GROUP 135.000 € (+0,75 %)     SHURGARD 25.750 € (+0,39 %)     BEKAERT 39.750 € (-2,09 %)     ONTEX GROUP 3.345 € (+0,60 %)     ENERGYVISION 12.500 € (+0,24 %)     COLRUYT 35.660 € (+0,96 %)     VIOHALCO 12.780 € (-3,18 %)     ORANGE BELGIUM 20.500 € (0,00 %)     BARCO 9.315 € (-2,10 %)     CFE 10.500 € (0,00 %)     IMMOBEL 21.800 € (+1,40 %)     SOLVAC NOM(RETAIL) 68.400 € (+0,88 %)     TESSENDERLO 20.500 € (-0,73 %)     XIOR 27.400 € (+1,86 %)     HOME INVEST BE. 19.100 € (+3,35 %)     ECONOCOM GROUP 1.400 € (-1,13 %)  
   SANOFI 82.580 € (-0,35 %)     ID LOGISTICS GROUP 325.500 € (-2,54 %)     EVERGREEN 0.170 € (+129,05 %)     VALEO 10.400 € (-4,98 %)     ADYEN 845.200 € (-2,14 %)     ING GROEP N.V. 22.945 € (-1,25 %)     WOLTERS KLUWER 65.320 € (+0,37 %)     KPN KON 4.848 € (+1,66 %)     KERING 265.250 € (+0,78 %)     STELLANTIS NV 6.574 € (+3,97 %)     Vusion 108.700 € (-2,16 %)     ALLFUNDS GROUP 8.600 € (+0,58 %)     THEON INTERNAT 34.000 € (+1,49 %)     ROBERTET 815.000 € (+0,25 %)     ASML HOLDING 1 161.000 € (-2,24 %)     NSE 49.500 € (-0,80 %)     TOUAX 3.940 € (0,00 %)     BNP PARIBAS ACT.A 83.300 € (-2,44 %)     FORVIA 9.944 € (-2,27 %)     KALRAY 3.405 € (-2,71 %)     POXEL 0.281 € (-11,91 %)     EXAIL TECHNOLOGIES 133.000 € (+1,53 %)     RUBIS 35.060 € (+0,57 %)     ORANGE 17.890 € (+1,22 %)     ASR NEDERLAND 60.920 € (+0,33 %)     AIRBUS 165.140 € (-1,64 %)     BOIRON 28.000 € (+1,08 %)     PLANISWARE 14.580 € (-0,82 %)     ARCELORMITTAL SA 45.660 € (-2,14 %)     PHILIPS KON 23.580 € (-0,08 %)     NOVACYT 0.373 € (-1,84 %)     ENGIE 28.970 € (+2,01 %)     STMICROELECTRONICS 29.085 € (-2,84 %)     BE SEMICONDUCTOR 190.150 € (+1,39 %)     WORLDLINE 0.289 € (+6,10 %)     DSM FIRMENICH AG 61.420 € (+1,12 %)     HEINEKEN HOLDING 62.850 € (+0,24 %)     EIFFAGE 135.700 € (-0,33 %)     SCHNEIDER ELECTRIC 236.150 € (-1,58 %)     2CRSI 28.700 € (-2,21 %)     SHELL PLC 40.605 € (+2,73 %)     FNAC DARTY 35.250 € (0,00 %)     LATECOERE 0.021 € (+5,05 %)     ALUMEXX N.V. 1.440 € (-1,37 %)     VINCI 131.600 € (-0,75 %)     NANOBIOTIX 27.400 € (-5,35 %)     PROSUS 40.020 € (-1,26 %)     FRANCAISE ENERGIE 41.050 € (+7,74 %)     AALBERTS NV 30.020 € (-2,09 %)     SAFRAN 287.300 € (-1,14 %)     INPOST 15.130 € (+0,07 %)     NEOVACS 0.001 € (-16,67 %)     ALPES (COMPAGNIE) 24.700 € (+1,23 %)     EURONEXT 143.300 € (+2,07 %)     MAUREL ET PROM 10.920 € (+7,48 %)     AHOLD DEL 41.730 € (+1,29 %)     ALTAMIR 24.600 € (0,00 %)     LHYFE 2.490 € (-0,20 %)     ABC ARBITRAGE 5.300 € (-0,93 %)     TOTALENERGIES 79.420 € (+2,40 %)  
News Réglementées
24/03/2026 09:00

Original-Research: q.beyond AG (von NuWays AG): BUY

Original-Research: q.beyond AG - from NuWays AG

24.03.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to q.beyond AG

Company Name:q.beyond AG
ISIN:DE000A41YDG0
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 6.5
Target price on sight of:12 months
Last rating change:
Analyst:Philipp Sennewald

QBY puts out upbeat 2028 targets; chg.

Yesterday, QBY presented its “Strategy 2028”, marking a pivotal shift in the investment narrative from a pure margin recovery story to a structured growth case. In detail:

For FY28, management targets € 250m in sales and a ~10% EBITDA margin (1.8x implied FY28 EV/EBITDA). The building blocks for these, in our view bullish, targets are a c. 5% organic sales CAGR, AI-driven upside and targeted M&A. This is underpinned by three strategic pillars:

Industry focus driving margins. Going forward, QBY intends to deepen its strongholds in logistics (€ 25m of FY25p sales) and retail (€ 50m), while entering healthcare and energy via M&A. Both new verticals currently feature fragmented IT landscapes and high regulatory complexity, thus posing a fertile ground for sovereign platforms like QBY’s. The M&A filter is disciplined, targeting companies with >10% EBITDA margins. While the strategic logic is sound, execution remains unproven . Encouragingly, management reiterated on the call that capital discipline takes precedence over deal velocity, even after having passed on several transactions last year on valuation grounds. A reassuring signal given the € 42m net cash position. Overall, M&A is expected to contribute c. € 20m towards the FY28 revenue target, with at least one deal anticipated in FY26 (eNuW). Note that future inorganic growth is not reflected in our estimates.

Top-line acceleration via AI orchestration. QBY is currently in the midst of transforming into a sovereign AI orchestrator for the German Mittelstand, building and operating industry-specific agents on its BSI-certified German data centre infrastructure. In our view, this is the most value-relevant pillar and it appears more tangible than typical AI strategy slides. The company already has a handful of paying external AI clients, is confident of reaching 20 by YE, and already has >300 agents deployed. The commercial model targets € 100-300k in recurring Managed Service sales per customer, with setup and development fees on top. The sovereign positioning creates a genuine moat against hyperscalers in the Mittelstand. However, the key open question is how quickly the recurring revenue share builds up, as the consulting-heavy early phase will be margin-dilutive before it inflects. Management targets >60 enterprise clients by FY28, translating into c. € 20m in AI revenues. We view this as ambitious and position ourselves more conservatively (eNuW: € 10m), preferring to see further tangible progress first.

Internationalisation. Nearshore hubs in Spain and Latvia are aimed to be converted into active sales hubs, targeting 10% international revenue share by FY28 vs. 3% today. This would pose a significant diversification away from the stagnating German market, though the financial impact remains comparably modest relative to the other two pillars.

Besides that, management targets FY26 sales of € 182-190m and € 10-16m, implying further margin expansion progress at mid-point. CEO Rixen confirmed on the call that the lower end represents a pure macro stress scenario and not a strategic investment drag, leaving the underlying margin trajectory intact.

That said, valuation remains highly undemanding, as shares are trading at only 3.0x FY26e EV/EBITDA. BUY, new PT of € 6.50 (post capital reduction) based on DCF.

You can download the research here: qbeyond-ag-2026-03-24-update-en-11fd8
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2296380  24.03.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière